Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | AZN | AMGN | GILD | VRTX |
| Company | Sarepta Therapeutics | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 16.98 | 69.59 | 300.93 | 109.85 | 467.00 |
| High | 19.18 | 69.61 | 301.00 | 110.90 | 467.00 |
| Low | 12.81 | 68.67 | 293.75 | 108.04 | 458.14 |
| Last | 14.07 | 68.79 | 294.76 | 108.22 | 459.81 |
| Change | -7.89 | -0.47 | -3.49 | -0.58 | -3.46 |
| % Change | -35.94% | -0.68% | -1.17% | -0.53% | -0.75% |
| Volume | 78,437,695 | 2,992,100 | 1,967,600 | 6,628,000 | 975,100 |
| 20-Day Average Volume | 10,327,215 | 4,048,445 | 2,642,505 | 7,542,385 | 1,217,260 |
| Previous Close | 21.97 | 69.26 | 298.25 | 108.80 | 463.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 18.29 | 70.31 | 290.22 | 110.01 | 458.08 |
| 20-Day Raw Stochastic | 12.59% | 4.55% | 77.95% | 36.12% | 48.17% |
| 20-Day Relative Strength | 30.22% | 43.25% | 53.31% | 48.14% | 50.66% |
| Weighted Alpha | -83.51 | -11.92 | -7.98 | +41.75 | -5.15 |
| Today's Opinion | 100% Sell | 72% Sell | 24% Buy | 56% Buy | 24% Sell |
| Previous Opinion | 88% Sell | 72% Sell | 24% Buy | 72% Buy | 8% Sell |
| Last Month's Opinion | 100% Sell | 8% Buy | 24% Sell | 72% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -22.54% since 07/11/25 | -3.29% since 07/11/25 | -0.17% since 07/11/25 | -1.30% since 07/11/25 | -1.93% since 07/11/25 |
| Low | 12.81 on 07/18/25 | 68.61 on 07/17/25 | 291.94 on 07/15/25 | 108.04 on 07/18/25 | 458.14 on 07/18/25 |
| High | 22.86 on 07/17/25 | 72.21 on 07/14/25 | 301.00 on 07/18/25 | 112.18 on 07/14/25 | 475.29 on 07/15/25 |
| 1-Month | |||||
| %Chg | -32.23% since 06/18/25 | -2.78% since 06/18/25 | +1.77% since 06/18/25 | +0.20% since 06/18/25 | +2.54% since 06/18/25 |
| Low | 12.81 on 07/18/25 | 68.61 on 07/17/25 | 267.83 on 06/23/25 | 104.46 on 06/25/25 | 436.80 on 06/20/25 |
| High | 22.86 on 07/17/25 | 72.46 on 07/10/25 | 302.38 on 07/10/25 | 114.87 on 07/10/25 | 484.56 on 07/10/25 |
| 3-Month | |||||
| %Chg | -73.83% since 04/17/25 | +1.78% since 04/17/25 | +6.30% since 04/17/25 | +3.52% since 04/17/25 | -5.99% since 04/17/25 |
| Low | 12.81 on 07/18/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 93.37 on 04/25/25 | 416.60 on 05/14/25 |
| High | 64.80 on 05/05/25 | 75.38 on 06/12/25 | 302.38 on 07/10/25 | 114.87 on 07/10/25 | 510.77 on 04/30/25 |
| 6-Month | |||||
| %Chg | -88.07% since 01/17/25 | +3.29% since 01/17/25 | +8.32% since 01/17/25 | +17.84% since 01/17/25 | +8.96% since 01/17/25 |
| Low | 12.81 on 07/18/25 | 61.24 on 04/09/25 | 261.43 on 05/14/25 | 91.84 on 01/22/25 | 416.60 on 05/14/25 |
| High | 120.05 on 02/05/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,383,249 | 213,339,520 | 158,494,224 | 134,617,984 | 118,077,832 |
| Shares Outstanding, K | 98,277 | 3,101,316 | 537,706 | 1,243,929 | 256,797 |
| Annual Sales | 1,901,980,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | 235,240,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 744,860,000 | 13,588,000,000 | 8,149,000,000 | 6,667,000,000 | 2,770,200,000 |
| Last Quarter Net Income | -447,510,000 | 2,921,000,000 | 1,730,000,000 | 1,315,000,000 | 646,300,000 |
| 60-Month Beta | 0.45 | 0.37 | 0.49 | 0.29 | 0.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -3.42 on 05/06/25 | 1.24 on 04/29/25 | 4.90 on 05/01/25 | 1.81 on 04/24/25 | 4.06 on 05/05/25 |
| Latest Earnings Date | 08/06/25 | 07/29/25 | 08/05/25 | 08/14/25 | 08/04/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 05/16/25 | 0.790 on 06/13/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 06/13/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.03 | 14.37 | 14.06 | 0.00 |